A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : FTLD / frontotemporal lobar degeneration

[Related PubMed/MEDLINE]
Total Number of Papers: 1191
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   FTLD  (>> Co-occurring Abbreviation)
Long Form:   frontotemporal lobar degeneration
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway. ALS
2019 Altered Brain Expression of Insulin and Insulin-Like Growth Factors in Frontotemporal Lobar Degeneration: Another Degenerative Disease Linked to Dysregulation of Insulin Metabolic Pathways. BA, BDNF, HNE, IGF-1, IGF2, pTau, TGF-beta1
2019 An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-kappaB signalling and is associated with reduced phosphorylation of p62. ALS
2019 Apathy and Disinhibition Related to Neuropathology in Amnestic Versus Behavioral Dementias. AD, bvFTD, DAT
2019 Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. ---
2019 Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS. ALS, HRE
2019 Astrocytic ceramide as possible indicator of neuroinflammation. AD, PDD, S1P
2019 Autopsy findings in the early stage of amyotrophic lateral sclerosis with "dropped head" syndrome. ALS, DHS, pTDP-43, TDP-43
2019 Behavioural impairments in mice of a novel FUS transgenic line recapitulate features of frontotemporal lobar degeneration. ALS, FUS
10  2019 Biomarkers for diseases with TDP-43 pathology. ALS, TDP-43
11  2019 C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation. cTDP-43, pTDP-43, TDP-43
12  2019 Cancer-related genes and ALS. ALS, caz, FUS, NPM-hMLF1
13  2019 Cerebrospinal Fluid Amyloid-beta Subtypes in Confirmed Frontotemporal Lobar Degeneration Cases: A Pilot Study. AD, CSF, FTD, PIB-PET
14  2019 Clinical Correlates of Alzheimer's Disease Cerebrospinal Fluid Analytes in Primary Progressive Aphasia. Abeta1-42, AD, CSF, lvPPA, PPA
15  2019 Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia. CSF, NfL, SD
16  2019 Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration. LBD, MSA
17  2019 Comparison of clinical and neuropathological diagnoses of neurodegenerative diseases in two centres from the Brains for Dementia Research (BDR) cohort. AD, BDR, DLB, FTD
18  2019 Corticospinal tract degeneration and temporal lobe atrophy in frontotemporal lobar degeneration TDP-43 type C pathology. SD, TDP-43
19  2019 Diagnostic imaging of dementia with Lewy bodies, frontotemporal lobar degeneration, and normal pressure hydrocephalus. DLB, NPH
20  2019 Disease-modifying therapies for tauopathies: agents in the pipeline. FTD
21  2019 Divergent patterns of TDP-43 and tau pathologies in primary progressive aphasia. MFC, OFC, PPA, SE
22  2019 Elevated YKL-40 and low sAPPbeta:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD. AUC, CSF
23  2019 Evidence of corticofugal tau spreading in patients with frontotemporal dementia. FTD
24  2019 Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers. CDKL1, DPR, eEF-2K, FDR, MND, SGSM3, VEGF-A
25  2019 FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations. ALS, C9FTLD
26  2019 Foix-Chavany-Marie syndrome due to type E TDP43 pathology. FCMS, PPA
27  2019 Frontotemporal dementia-associated protein "phosphorylated TDP-43" localizes to atherosclerotic lesions of human carotid and main cerebral arteries. ALS, HMGB1, TARDP
28  2019 Fused in Sarcoma: Properties, Self-Assembly and Correlation with Neurodegenerative Diseases. ALS, FUS, LLPS, PrLDs
29  2019 Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome Pathway. AD, ALP
30  2019 Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia. svPPA
31  2019 Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues. ---
32  2019 Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS. FUS, hnRNP
33  2019 HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease. AD, HCs, HD, IAs, IAs, PD
34  2019 Immunological signatures in frontotemporal lobar degeneration. FTD
35  2019 Incidence of frontotemporal lobar degeneration in Italy: The Salento-Brescia Registry study. CI, PY
36  2019 Increased risk of melanoma in C9ORF72 repeat expansion carriers: A case-control study. ALS
37  2019 Increased Tau Phosphorylation in Motor Neurons From Clinically Pure Sporadic Amyotrophic Lateral Sclerosis Patients. ALS, pS396
38  2019 Inherited and Sporadic Amyotrophic Lateral Sclerosis and Fronto-Temporal Lobar Degenerations arising from Pathological Condensates of Phase Separating Proteins. ALS
39  2019 Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients. GlycA, HDL, hs-CRP
40  2019 Memory Decline and Its Reversal in Aging and Neurodegeneration Involve miR-183/96/182 Biogenesis. ALS, miRNAs, PP1, R-SMAD
41  2019 Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations. ---
42  2019 Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases. AD, NCL, PGRN
43  2019 Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion. ALS, C9orf72, FTD, TDP-43
44  2019 Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. ALS, LLPS, TDP-43
45  2019 Mutation Analysis of the Genes Linked to Early Onset Alzheimer's Disease and Frontotemporal Lobar Degeneration. AD, EOD
46  2019 Neuroinflammation in frontotemporal lobar degeneration revealed by 11 C-PBR28 PET. MRI, PET, TSPO
47  2019 New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures. ---
48  2019 Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism. AD, GRN, HM, MGnD, TREM2
49  2019 Overexpression of human wtTDP-43 causes impairment in hippocampal plasticity and behavioral deficits in CAMKII-tTa transgenic mouse model. alpha-Syn, DLB, PCP4, PD, rAAV, wtTDP-43
50  2019 Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases. ALS
51  2019 Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains. NFT
52  2019 Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion. ---
53  2019 Peripheral Innate Immune Activation Correlates With Disease Severity in GRN Haploinsufficiency. FA
54  2019 Preferential tau aggregation in von Economo neurons and fork cells in frontotemporal lobar degeneration with specific MAPT variants. ACC, bvFTD, FI, FTD, FTLD-tau, PiD, VENs
55  2019 Prevalence of C9ORF72 Expansion in a Large Series of Patients with Idiopathic Normal-Pressure Hydrocephalus. ALS, iNPH
56  2019 Progranulin deficiency leads to reduced glucocerebrosidase activity. GCase, NCL, PGRN
57  2019 Prominent microglial activation in cortical white matter is selectively associated with cortical atrophy in primary progressive aphasia. AD, PPA
58  2019 PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies. AD, ALS, UPS
59  2019 Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia. NCL
60  2019 Review: Molecular pathology of frontotemporal lobar degenerations. FUS, TDP-43
61  2019 Review: Neuropathology of non-tau frontotemporal lobar degeneration. FTD
62  2019 RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration. ---
63  2019 Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest. AD, CSF, FTD, t-tau
64  2019 Semantic deficits in ALS related to right lingual/fusiform gyrus network involvement. ALS, HCs
65  2019 Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders. bvFTD, CSF, NfL, PPD, sNfL
66  2019 SMCR8 negatively regulates AKT and MTORC1 signaling to modulate lysosome biogenesis and tissue homeostasis. ALS
67  2019 Speech and language intervention for language impairment in patients in the FTD-ALS spectrum. ALS, FTD, PPA, SLT
68  2019 Suppression of Progranulin Expression Leads to Formation of Intranuclear TDP-43 Inclusions In Vitro: A Cell Model of Frontotemporal Lobar Degeneration. PGRN, TDP-43
69  2019 Sustained attention failures on a 3-min reaction time task is a sensitive marker of dementia. AD, PVT, RT
70  2019 Tau isoform expression and phosphorylation in marmoset brains. AD
71  2019 TDP-43 and FUS-structural insights into RNA recognition and self-association. ALS
72  2019 TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. ALS, pTDP-43
73  2019 TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. ALS, EM, ROS
74  2019 The association between repeat number in C9orf72 and phenotypic variability in Turkish patients with frontotemporal lobar degeneration. ---
75  2019 The Impact of Cerebral Amyloid Angiopathy in Various Neurodegenerative Dementia Syndromes: A Neuropathological Study. AD, CAA, CBD, LBD, PSP
76  2019 The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD. ALS, CTFs
77  2019 The role of lysosomes and autophagosomes in frontotemporal lobar degeneration. CTSD, DG, LAMP1, LC3A, TCX
78  2019 The Role of TDP-43 in Military-Relevant TBI and Chronic Neurodegeneration. IEDs, rbTBI, TBI
79  2019 The Role of the Right Hemisphere in Emotional and Behavioral Disorders of Patients With Frontotemporal Lobar Degeneration: An Updated Review. ---
80  2019 The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion. AD
81  2019 The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability. ALS, FTD, nfvPPA, PPA, svPPA
82  2019 Transcriptomopathies of pre- and post-symptomatic frontotemporal dementia-like mice with TDP-43 depletion in forebrain neurons. ALS
83  2019 Use of the CDR plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium. BEHAV, CDR, CDR-SB, LANG
84  2019 Using Tetracysteine-Tagged TDP-43 with a Biarsenical Dye To Monitor Real-Time Trafficking in a Cell Model of Amyotrophic Lateral Sclerosis. ALS, TDP-43
85  2018 A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes. Abeta1-42, AD, AUC, CSF, FTD, p-tau, t-tau
86  2018 A case of semantic variant primary progressive aphasia with Pick's pathology. svPPA, VBM
87  2018 A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies. AD, TAOKs
88  2018 A Review: Mealtime Difficulties following Frontotemporal Lobar Degeneration. ---
89  2018 Aging and cerebrovascular lesions in pure and in mixed neurodegenerative and vascular dementia brains: aneuropathological study. AD, CAA, CoMBs, CoMIs, LBD, WMCs
90  2018 Altered Expression of Circulating Cdc42 in Frontotemporal Lobar Degeneration. AD, Cdc42
91  2018 Amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD) are characterised by differential activation of ER stress pathways: focus on UPR target genes. AD, ALS, ER, ERAD, UPR
92  2018 Analysis of the substrate recognition state of TDP-43 to single-stranded DNA using fluorescence correlation spectroscopy. ALS, EMSA, FCS, ssDNA, TAR
93  2018 Argyrophilic Grain Pathology in Frontotemporal Lobar Degeneration: Demographic, Clinical, Neuropathological, and Genetic Features. AGD, PSP
94  2018 Atypical parkinsonian syndromes: a general neurologist's perspective. FTD, PPA
95  2018 Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression. AD, ALS, CJD, CON, CSF, DCo, PD
96  2018 Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration. bvFTD, FUS, MND, TDP
97  2018 Clinical utility of FDG-PET for the clinical diagnosis in MCI. AD, DLB, FDG, MCI, PICO
98  2018 Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia. AD, DLB, VaD
99  2018 Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum. FTD, FTD-MND, lvPPA, NfL, PPA
100  2018 Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. AD, CSF, Nf-L, t-tau